Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Grace Therapeutics (NASDAQ:GRCE) through any online brokerage.
There are no as such competitors for Grace Therapeutics.
Grace Therapeutics has a consensus price target of $10.00.
The stock price for Grace Therapeutics (NASDAQ: GRCE) is $2.48 last updated July 10, 2026 at 9:25 AM EDT.
There are no upcoming dividends for Grace Therapeutics.
Grace Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Grace Therapeutics.
Grace Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.